HIV/AIDS: Kenyan study portends end of second line treatment
A study conducted at the Moi Teaching and Referral Hospital (MTRH) clinic in Eldoret, by AMPATH, a partnership between the hospital and other Kenyan clinics with the Kenyan government and American Universities have found very high levels of drug resistance among patients on second-line treatment for people living with HIV.
Released at the ongoing HIV Research for Prevention (HIVR4P 2018) in Madrid, Spain, the study, according to experts, suggests that current treatment failure guidelines may need to be revised – and poses the question of how to resource them.
At the MTRH clinic, 18,282 adults with HIV are currently in care, of whom 76% are on antiretroviral therapy (ART). Ninety-one per cent of these is on first-line ART.